Arriving in the arena of excess body fat therapy, retatrutide presents a different strategy. Unlike many existing medications, retatrutide works as a twin agonist, concurrently targeting both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) receptors. This dual engagement fosters multiple beneficial effects, such as improv… Read More